Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Orthopedics Market Research

Orthopedic Biomaterials Market Size, Share and Trends Analysis - Europe - 2024-2030 - MedSuite - Includes: Bone Graft Substitutes, Orthopedic Growth Factors, and 3 more

Best Price Guarantee Length Publisher Published Date SKU
from $8,995 464 Pages iData Research, Inc. October, 2024 IDR19249253
Best Price Guarantee
Price from $8,995
Length 464 Pages
Publisher iData Research, Inc.
Published Date October, 2024
SKU IDR19249253

Orthopedic Biomaterials Market Size, Share and Trends Analysis | Europe | 2024-2030 | MedSuite | Includes: Bone Graft Substitutes, Orthopedic Growth Factors, and 3 more


In 2023, the European market for orthopedic biomaterials was valued at over €554 million. This market is projected to grow at a compound annual growth rate (CAGR) of 2.1%, reaching nearly €643 million by 2030. The full report on the European orthopedic biomaterials market includes bone graft substitutes (allografts, demineralized bone matrices (DBMs), and synthetic bone grafts), orthopedic growth factors, cell therapies (bone marrow aspirate concentrate and platelet-rich plasma), hyaluronic acid (HA) viscosupplementation (single-, two-, three-, and five-injection cycles), and orthopedic cartilage repair (osteochondral allografts, meniscal allografts, autologous chondrocyte implantation, and osteochondral autografts).

MARKET DATA HIGHLIGHTS:

Unit sales, average selling prices, market value, and growth trends
Forecasts until 2030 and historical data from 2020
Market drivers and constraints for each segment
Competitive analysis with market shares for each segment
Mergers & acquisitions
Procedure volumes
Company profiles, product portfolios, and SWOT analysis for top competitors

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET TRENDS

Key demographic trends continue to drive the European orthopedic biomaterials market. A notable factor is the rising incidence of osteoarthritis (OA) in the spine, particularly as the population ages, leading to an increasing number of spinal fusion procedures. With the aging population, driven by the retirement of the first wave of baby boomers starting in 2008, there has been a growing demand for treatments addressing arthritis and degenerative disc disease. This has led to an increased need for bone graft substitutes. Additionally, the prevalence of degenerative diseases is further accelerated by rising obesity rates, driving demand for orthopedic biomaterials and associated procedures. These trends are expected to propel market growth during the forecast period.

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET SHARE INSIGHTS (2023)

Fidia maintained its leadership position in the European orthopedic biomaterials market, bolstered by the strong performance of its HA viscosupplementation products, Hyalubrix® and Hyalgan®.
Medtronic ranked as the second-largest player, largely due to its dominance in the orthopedic growth factor market with its INFUSE™ product.
Bioventus secured the third-largest market share, primarily as the leading distributor of DUROLANE®, a single-injection treatment, across Europe.

MARKET SEGMENTATION SUMMARY

Bone Graft Substitutes Market: Includes allografts, demineralized bone matrices (DBMs), and synthetic bone graft substitutes.
Orthopedic Growth Factor Market: Segmented into spine and tibial fracture treatments.
Orthopedic Cell Therapy Market: Includes platelet-rich plasma and bone marrow concentration segments.
Hyaluronic Acid Viscosupplementation Market: Covers single-injection, two-injection, three-injection, and five-injection products.
Orthopedic Cartilage Repair Market: Includes osteochondral allografts, meniscal allografts, autologous chondrocyte implantation (ACI), and osteochondral autografts.

GLOBAL RESEARCH SCOPE SUMMARY

Region: Europe (France, U.K., Italy, Spain, Benelux, Scandinavia, Austria, Switzerland, Portugal)
Base Year: 2023
Forecast: 2024-2030
Historical Data: 2020-2022
Quantitative Coverage: Market size, market shares, market forecasts, market growth rates, units sold, and average selling prices.
Qualitative Coverage: COVID-19 impact, market growth trends, market constraints, competitive analysis, SWOT for top competitors, mergers & acquisitions, company profiles, product portfolios, FDA recalls, disruptive technologies, disease overviews.
Data Sources: Primary interviews with industry leaders, government physician data, regulatory data, hospital private data, import/export data, iData Research’s internal database.


executive summary
European Orthopedic Biomaterials Market Overview
Competitive Analysis
Emerging Markets and Technologies
Market Trends
Market Developments
Market Segmentation
Procedure Segmentation
Key Report Updates
Version History
research methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
impact of covid-19 on THE European Orthopedic Biomaterials Market
2.1 Introduction
2.1.1 Treatable Population
2.2 Country Profiles
2.3 Analysis By Market Segment
2.3.1 Worst Case Scenario
2.3.2 Base Case Scenario
2.3.3 Best Case Scenario
Product Assessment
3.1 Introduction
3.2 Product Portfolios
3.2.1 Bone Graft Substitutes
3.2.2 Growth Factors
3.2.2.1.1 NELL-1 Bone Biologics
3.2.2.1.2 INFUSE® by Medtronic
3.2.2.1.3 OsteoAMP® by Bioventus Surgical
3.2.2.1.4 OP-1™ by Stryker/Olympus Biotech (Delisted)
3.2.2.1.5 The Osteogrow Study
3.2.2.1.6 AUGMENT® Bone Graft
3.2.2.1.7 Amplex® Osteobiologic Bone Graft Substitute
3.2.2.1.8 i-Factor™ Peptide Bone Matrix
3.2.3 Cell Therapy
3.2.3.1 Platelet-Rich Plasma
3.2.3.2 Bone Marrow Aspirate Concentrate
3.2.4 Hyaluronic Acid Viscosupplementation (HAV)
3.2.5 Cartilage Repair
3.3 Regulatory Issues and Recalls
3.3.1 Bone Graft Substitute Market FDA Recalls
3.3.2 Growth Factor Market FDA Recalls
3.4 Clinical Trials
3.4.1 Bone Graft Substitute Market Clinical Trials
3.4.2 Growth Factor Market Clinical Trials
3.4.3 Cell Therapy Market Clinical Trials
3.4.4 Hyaluronic Acid Viscosupplementation Market
3.4.5 Cartilage Repair Market Clinical Trials
European Orthopedic Biomaterials Market Overview
4.1 Introduction
4.2 Currency Exchange Rate
4.3 Market Overview & Trend Analysis
4.4 Drivers and Limiters
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 Competitive Market Share Analysis
4.6 Mergers and Acquisitions
4.7 Company Profiles
4.7.1 Arthrex
4.7.2 Biocomposites
4.7.3 Bioventus
4.7.4 DePuy Synthes
4.7.5 Ferring Pharmaceuticals
4.7.6 Isto Biologics
4.7.7 Medtronic
4.7.8 MTF
4.7.9 NuVasive
4.7.10 Orthofix
4.7.11 Sanofi
4.7.12 Stryker
4.7.13 Terumo
4.7.14 Vericel
4.7.15 Zimmer Biomet
4.8 SWOT Analysis
4.8.1 Arthrex
4.8.2 Biocomposites
4.8.3 Bioventus
4.8.4 DePuy Synthes
4.8.5 Ferring Pharmaceuticals
4.8.6 Isto Biologics
4.8.7 Medtronic
4.8.8 MTF
4.8.9 NuVasive
4.8.10 Orthofix
4.8.11 Sanofi
4.8.12 Stryker
4.8.13 Terumo
4.8.14 Vericel
4.8.15 Zimmer Biomet
Country Profiles
5.1 Introduction
5.1.1 GDP Per Capita
5.1.2 Price Index
5.2 Germany
5.3 France
5.4 United Kingdom
5.5 Italy
5.6 Spain
5.7 Benelux
5.8 Scandinavia
5.9 Austria
5.10 Switzerland
5.11 Portugal
Procedure Numbers
6.1 Introduction
6.2 Procedures
6.2.1 Orthopedic Bone Grafting Procedures
6.2.1.1 Orthopedic Bone Grafting Procedures by Material
6.2.1.2 Orthopedic Bone Grafting Procedures by Indication
6.2.1.2.1 Average Units Used per Procedure by Indication
6.2.1.3 Allograft Procedures by Indication
6.2.1.4 DBM Procedures by Indication
6.2.1.5 Synthetic Procedures by Indication
6.2.1.6 Orthopedic Bone Grafting Procedures by Care Setting
6.2.2 Orthopedic Growth Factor Procedures
6.2.2.1 Orthopedic Growth Factor Procedures by Indication
6.2.2.2 Orthopedic Growth Factor Procedures by Care Setting
6.2.3 Orthopedic Cell Therapy Procedures
6.2.3.1 Orthopedic Cell Therapy Procedures by Material Type
6.2.3.2 Platelet-Rich Plasma Procedures
6.2.3.3 Bone Marrow Aspirate Concentrate Procedures
6.2.3.1 Orthopedic Cell Therapy Procedures by Care Setting
6.2.4 Hyaluronic Acid Viscosupplementation Procedures
6.2.4.1 Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle
6.2.4.1 Hyaluronic Acid Viscosupplementation Procedures by Care Setting
6.2.5 Orthopedic Cartilage Repair Procedures
6.2.5.1 Orthopedic Cartilage Repair Procedures by Type
6.2.5.2 Orthopedic Cartilage Repair Procedures by Care Setting
orthopedic Bone Graft Substitute Market
7.1 Introduction
7.2 Market Overview
7.3 Market Analysis and Forecast
7.3.1 Total Bone Graft Substitute Market
7.3.2 Allograft Bone Graft Substitute Market
7.3.3 Demineralized Bone Matrix Bone Graft Substitute Market
7.3.4 Synthetic Bone Graft Substitute Market
7.4 Unit Analysis
7.4.1 Total Bone Graft Substitute Unit Analysis
7.4.2 Allograft Bone Graft Substitute Unit Analysis
7.4.2.1 Allograft Bone Graft Substitute Units Sold by Indication
7.4.2.1.1 Spine Allograft Bone Graft Substitute Units Sold by Anatomy
7.4.2.1.2 Trauma Allograft Bone Graft Substitute Units Sold by Anatomy
7.4.2.1.3 Large Joint Reconstruction Allograft Bone Graft Substitute Units Sold by Anatomy
7.4.2.1.4 Foot Reconstruction Allograft Bone Graft Substitute Units Sold
7.4.2.1.5 Craniomaxillofacial Allograft Bone Graft Substitute Units Sold
7.4.2.1.6 Oncology Allograft Bone Graft Substitute Units Sold
7.4.3 Demineralized Bone Matrix Allograft Unit Analysis
7.4.3.1 Demineralized Bone Matrix Allograft Units Sold by Indication
7.4.3.1.1 Spine Demineralized Bone Matrix Allograft Units Sold by Anatomy
7.4.3.1.2 Trauma Demineralized Bone Matrix Allograft Units Sold by Anatomy
7.4.3.1.3 Craniomaxillofacial Demineralized Bone Matrix Allograft Units Sold
7.4.4 Synthetic Bone Graft Substitute Unit Analysis
7.4.4.1 Synthetic Bone Graft Substitute Units Sold by Indication
7.4.4.1.1 Spine Synthetic Bone Graft Substitute Units Sold by Anatomy
7.4.4.1.2 Trauma Synthetic Bone Graft Substitute Units Sold by Anatomy
7.4.4.1.3 Large Joint Reconstruction Synthetic Bone Graft Substitute Units Sold by Anatomy
7.4.4.1.4 Foot Reconstruction Synthetic Bone Graft Substitute Units Sold
7.4.4.1.5 Craniomaxillofacial Synthetic Bone Graft Substitute Units Sold
7.4.4.1.6 Oncology Synthetic Bone Graft Substitute Units Sold
7.4.4.2 Synthetic Bone Graft Substitute Market by Generation Type
7.4.4.2.1 Generation 1 Synthetic Bone Graft Substitute Market
7.4.4.2.2 Generation 2 Synthetic Bone Graft Substitute Market
7.5 Drivers and Limiters
7.5.1 Market Drivers
7.5.2 Market Limiters
7.6 Competitive Market Share Analysis
ORthopedic Growth Factor Market
8.1 Introduction
8.1.1 BMP-2 (Medtronic)
8.2 Market Overview
8.3 Market Analysis and Forecast
8.3.1 Orthopedic Growth Factor Market
8.3.2 Spine Fracture Orthopedic Growth Factor Market
8.3.3 Tibial Fracture Orthopedic Growth Factor Market
8.4 Unit Analysis
8.4.1 Spine Orthopedic Growth Factor Unit Analysis
8.4.2 Tibial Fracture Orthopedic Growth Factor Unit Analysis
8.5 Drivers and Limiters
8.5.1 Market Drivers
8.5.2 Market Limiters
8.6 Competitive Market Share Analysis
Orthopedic Cell Therapy Market
9.1 Introduction
9.2 Market Overview
9.3 Market Analysis and Forecast
9.3.1 Platelet-Rich Plasma Market
9.3.2 Bone Marrow Aspirate Concentrate Market
9.4 Unit Analysis
9.4.1 Platelet-Rich Plasma Units Sold by Indication
9.4.1.1 Soft-Tissue Platelet-Rich Plasma Units Sold
9.4.1.2 Spine Platelet-Rich Plasma Units Sold
9.4.1.3 Cardiac Platelet-Rich Plasma Units Sold
9.4.1.4 Orthopedic Platelet-Rich Plasma Units Sold
9.4.1.5 Plastics Platelet-Rich Plasma Units Sold
9.4.2 Bone Marrow Aspirate Concentrate Units Sold by Indication
9.4.2.1 Spine Bone Marrow Aspirate Concentrate Units Sold
9.4.2.2 Soft-Tissue Bone Marrow Aspirate Concentrate Units Sold
9.4.2.3 Trauma Bone Marrow Aspirate Concentrate Units Sold
9.4.2.4 Joint Reconstruction Bone Marrow Aspirate Concentrate Units Sold
9.5 Drivers and Limiters
9.5.1 Market Drivers
9.5.2 Market Limiters
9.6 Competitive Market Share Analysis
Hyaluronic Acid Viscosupplementation Market
10.1 Introduction
10.1.1 Benefits of Viscosupplementation
10.1.2 Synovial Fluid
10.1.3 Product Types
10.2 Market Overview
10.3 Market Analysis and Forecast
10.3.1 Total Hyaluronic Acid Viscosupplementation Market
10.3.2 Single-Injection Hyaluronic Acid Viscosupplementation Market
10.3.3 Two-Injection Hyaluronic Acid Viscosupplementation Market
10.3.4 Three-Injection Hyaluronic Acid Viscosupplementation Market
10.3.5 Five-Injection Hyaluronic Acid Viscosupplementation Market
10.4 Drivers and Limiters
10.4.1 Market Drivers
10.4.2 Market Limiters
10.5 Competitive Market Share Analysis
Orthopedic Cartilage Repair Market
11.1 Introduction
11.1.1 Anatomy
11.1.2 Methods for Cartilage Repair
11.1.2.1 Osteochondral Allograft Transfer
11.1.2.2 Autologous Chondrocyte Implantation (ACI)
11.1.2.3 Meniscal Allograft Transplantation
11.1.2.4 Osteochondral Autograft
11.2 Market Overview
11.3 Market Analysis and Forecast
11.3.1 Osteochondral Allograft Market
11.3.2 Meniscal Allograft Market
11.3.3 Autologous Chondrocyte Implantation Market
11.3.4 Osteochondral Autograft Market
11.4 Drivers and Limiters
11.4.1 Market Drivers
11.4.2 Market Limiters
11.5 Competitive Market Share Analysis
Abbreviations
Chart 1-1: Orthopedic Biomaterials Market by Segment, Europe, 2023
Chart 1-2: Orthopedic Biomaterials Market Overview, Europe, 2023 & 2030
Chart 2-1: Multi-Scenario Orthopedic Biomaterials Market Forecast, Europe, 2020 – 2030 (€M)
Chart 4-1: Orthopedic Biomaterials Market by Segment, Europe, 2020 – 2030
Chart 4-2: Leading Competitors, Orthopedic Biomaterials Market, Europe, 2023
Chart 5-1: Country Profile, Germany, 2023
Chart 5-2: Country Profile, France, 2023
Chart 5-3: Country Profile, United Kingdom, 2023
Chart 5-4: Country Profile, Italy, 2023
Chart 5-5: Country Profile, Spain, 2023
Chart 5-6: Country Profile, Benelux, 2023
Chart 5-7: Country Profile, Scandinavia, 2023
Chart 5-8: Country Profile, Austria, 2023
Chart 5-9: Country Profile, Switzerland, 2023
Chart 5-10: Country Profile, Portugal, 2023
Chart 7-1: Bone Graft Substitute Market by Segment, Europe, 2020 – 2030
Chart 7-2: Leading Competitors, Orthopedic Bone Graft Substitute Market, Europe, 2023
Chart 9-1: Orthopedic Cell Therapy Market by Segment, Europe, 2020 – 2030
Chart 9-2: Leading Competitors, Orthopedic Cell Therapy Market, Europe, 2023
Chart 10-1: Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2020 – 2030
Chart 10-2: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Europe, 2023
Chart 11-1: Orthopedic Cartilage Repair Market by Segment, Europe, 2020 – 2030
Chart 11-2: Leading Competitors, Orthopedic Cartilage Repair Market, Europe, 2023
Figure 1-1: Orthopedic Biomaterials Market Share Ranking by Segment, Europe, 2023
Figure 1-2: Companies Researched in This Report
Figure 1-3: Factors Impacting the Orthopedic Biomaterials Market by Segment, Europe (1 of 2)
Figure 1-4: Factors Impacting the Orthopedic Biomaterials Market by Segment, Europe (2 of 2)
Figure 1-5: Recent Events in the Orthopedic Biomaterials Market, Europe, 2021 – 2024 (1 of 7)
Figure 1-6: Recent Events in the Orthopedic Biomaterials Market, Europe, 2021 – 2024 (2 of 7)
Figure 1-7: Recent Events in the Orthopedic Biomaterials Market, Europe, 2021 – 2024 (3 of 7)
Figure 1-8: Recent Events in the Orthopedic Biomaterials Market, Europe, 2021 – 2024 (4 of 7)
Figure 1-9: Recent Events in the Orthopedic Biomaterials Market, Europe, 2021 – 2024 (5 of 7)
Figure 1-10: Recent Events in the Orthopedic Biomaterials Market, Europe, 2021 – 2024 (6 of 7)
Figure 1-11: Recent Events in the Orthopedic Biomaterials Market, Europe, 2021 – 2024 (7 of 7)
Figure 1-12: Orthopedic Biomaterials Market Segmentation, Europe (1 of 2)
Figure 1-13: Orthopedic Biomaterials Market Segmentation, Europe (2 of 2)
Figure 1-14: Orthopedic Biomaterials Procedure Segmentation, Europe (1 of 3)
Figure 1-15: Orthopedic Biomaterials Procedure Segmentation, Europe (2 of 3)
Figure 1-16: Orthopedic Biomaterials Procedure Segmentation, Europe (3 of 3)
Figure 1-17: Key Report Updates (1 of 2)
Figure 1-18: Version History
Figure 2-1: Orthopedic Biomaterials Market by Segment, Worst Case Scenario, Europe, 2020 – 2030 (€M)
Figure 2-2: Orthopedic Biomaterials Market by Segment, Base Case Scenario, Europe, 2020 – 2030 (€M)
Figure 2-3: Orthopedic Biomaterials Market by Segment, Best Case Scenario, Europe, 2020 – 2030 (€M)
Figure 3-1: Bone Graft Substitutes Products by Company (1 of 4)
Figure 3-2: Bone Graft Substitutes Products by Company (2 of 4)
Figure 3-3: Bone Graft Substitutes Products by Company (3 of 4)
Figure 3-4: Bone Graft Substitutes Products by Company (4 of 4)
Figure 3-5: Growth Factor Products by Company
Figure 3-6: Cell Therapy Products by Company
Figure 3-7: Hyaluronic Acid Viscosupplementation by Products by Company
Figure 3-8: Cartilage Repair Products by Company
Figure 3-9: Class 2 Device Recall GRAFTON DBM (Gel, Flex, Putty, Matrix, Crunch)
Figure 3-10: Class 2 Device Recall GRAFTON PLUS DBM Paste
Figure 3-11: Class 2 Device Recall Magnifuse Bone Graft
Figure 3-12: Class 2 Device Recall Grafton DBF Inject
Figure 3-13: Class 2 Device Recall OsteoSelect Demineralized Bone Matrix (DBM) Putty
Figure 3-14: Class 2 Device Recall PROSTIM 10cc INJECTABLE
Figure 3-15: Class 2 Device Recall Opteform Allograft Disc
Figure 3-16: Class 2 Device Recall Bioactive Bone Graft Putty
Figure 3-17: Class 3 Device Recall iFACTOR Peptide Enhanced Bone Graft Putty
Figure 3-18: ACDF Using Structural Allograft vs. Tritanium C
Figure 3-19: Clinical Study of Bone Graft Substitutes in Orthopaedic and Spinal Applications
Figure 3-20: OSTEOAMP Lumbar Fusion Intra-Patient Controlled Study
Figure 3-21: Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft. (BONE)
Figure 3-22: Demineralized Bone Matrix Rotator Cuff Study
Figure 3-23: Clinical Outcomes Associated with the Use of ViviGen® for the Treatment of Lumbar Degenerative Disc Disease
Figure 3-24: The Effect of Bone-void Filler on Anterior Knee Pain Following ACL Reconstruction
Figure 3-25: Long-term Safety and Effectiveness of AUGMENT® Injectable Bone Graft Compared to Autologous Bone Graft
Figure 3-26: Transforaminal Lumbar Interbody Fusion (TLIF)
Figure 3-27: A Post Market Surveillance on INFUSE Bone Graft
Figure 3-28: Long-term Safety and Effectiveness of AUGMENT® Injectable Bone Graft Compared to Autologous Bone Graft
Figure 3-29: Evaluation of the Effectiveness of AMPLEX® Compared to Autogenous Bone Grafts
Figure 3-30: Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies
Figure 3-31: Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection
Figure 3-32: BMAC & Allograft vs BMP-2
Figure 3-33: Bone Marrow Aspirate Concentrate (BMAC)Treatment for Knee Osteoarthritis (BMAC)
Figure 3-34: Platelet Rich Plasma in Knee Osteoarthritis
Figure 3-35: Platelet-Rich Plasma (PRP) for Treatment of Symptomatic Lumbar Facet Syndrome of the Spine
Figure 3-36: A Prospective Study of Clinical Outcomes Following a Single Intradiscal Injection of Bone Marrow Aspirate Concentrate (BMAC) for Single Level Discogenic Low Back Pain
Figure 3-37: ArtiAid® for Knee Osteoarthritis: A Post-market Study
Figure 3-38: The Effectiveness of Different Doses of Hyaluronic Acid Injections in Knee Osteoarthritis
Figure 3-39: Euflexxa for the Treatment of Osteoarthritis
Figure 3-40: MONOVISC for Ankle Joint Pain Relief
Figure 3-41: MONOVISC for Shoulder Joint Pain Relief
Figure 3-42: MONOVISC for Hip Joint Pain Relief
Figure 3-43: Comparison of Hyaluronic Acid and Platelet-Rich Plasma Injections
Figure 3-44: Prospective Evaluation of ProChondrix CR for Repair of Articular Cartilage Defects on Femoral Condyle and Patella
Figure 3-45: Osteochondral Allograft in the Surgical Treatment of Basal Joint Arthritis
Figure 3-46: Phase 2 Clinical Trial of CartiLife® in the United States
Figure 3-47: A Study to Evaluate the Efficacy of BioCartilage® Micronized Cartilage Matrix in Microfracture Treatment of Osteochondral Defects
Figure 4-1: Currency Exchange Rate, 2023
Figure 4-2: Orthopedic Biomaterials Market by Segment, Europe, 2020 – 2030 (€M)
Figure 4-3: Orthopedic Biomaterials Market by Segment, Europe, 2020 – 2030 (US$M)
Figure 4-4: Leading Competitors, Orthopedic Biomaterials Market, Europe, 2023 (1 of 2)
Figure 4-5: Leading Competitors, Orthopedic Biomaterials Market, Europe, 2023 (2 of 2)
Figure 4-6: SWOT Analysis, Arthrex
Figure 4-7: SWOT Analysis, Biocomposites
Figure 4-8: SWOT Analysis, Bioventus
Figure 4-9: SWOT Analysis, DePuy Synthes
Figure 4-10: SWOT Analysis, Ferring Pharmaceuticals
Figure 4-11: SWOT Analysis, Isto Biologics
Figure 4-12: SWOT Analysis, Medtronic
Figure 4-13: SWOT Analysis, MTF
Figure 4-14: SWOT Analysis, NuVasive
Figure 4-15: SWOT Analysis, Orthofix
Figure 4-16: SWOT Analysis, Sanofi
Figure 4-17: SWOT Analysis, Stryker
Figure 4-18: SWOT Analysis, Terumo
Figure 4-19: SWOT Analysis, Vericel
Figure 4-20: SWOT Analysis, Zimmer Biomet
Figure 6-1: Orthopedic Biomaterials Procedures by Segment, Europe, 2020 – 2030
Figure 6-2: Orthopedic Biomaterials Procedures by Segment, Europe, 2020 – 2030
Figure 6-3: Orthopedic Bone Grafting Procedures by Country, Europe, 2020 – 2030
Figure 6-4: Orthopedic Bone Grafting Procedures by Material, Europe, 2020 – 2030
Figure 6-5: Orthopedic Bone Grafting Procedures by Indication, Europe, 2020 – 2030 (1 of 2)
Figure 6-6: Orthopedic Bone Grafting Procedures by Indication, Europe, 2020 – 2030 (2 of 2)
Figure 6-7: Cervical Spine Procedures by Country, Europe, 2020 – 2030
Figure 6-8: Thoracolumbar Spine Procedures by Country, Europe, 2020 – 2030
Figure 6-9: Non-Union Trauma Procedures by Country, Europe, 2020 – 2030
Figure 6-10: Fresh Fracture Trauma Procedures by Country, Europe, 2020 – 2030
Figure 6-11: Hip Procedures by Country, Europe, 2020 – 2030
Figure 6-12: Knee Procedures by Country, Europe, 2020 – 2030
Figure 6-13: Foot Procedures by Country, Europe, 2020 – 2030
Figure 6-14: Craniomaxillofacial Procedures by Country, Europe, 2020 – 2030
Figure 6-15: Oncology Procedures by Country, Europe, 2020 – 2030
Figure 6-16: Average Units Used per Procedure by Indication, Europe, 2020 – 2030
Figure 6-17: Allograft Procedures by Country, Europe, 2020 – 2030
Figure 6-18: Allograft Procedures by Indication, Europe, 2020 – 2030 (1 of 2)
Figure 6-19: Allograft Procedures by Indication, Europe, 2020 – 2030 (2 of 2)
Figure 6-20: Allograft Cervical Spine Procedures by Country, Europe, 2020 – 2030
Figure 6-21: Allograft Thoracolumbar Spine Procedures by Country, Europe, 2020 – 2030
Figure 6-22: Allograft Non-Union Trauma Procedures by Country, Europe, 2020 – 2030
Figure 6-23: Allograft Fresh Fracture Trauma Procedures by Country, Europe, 2020 – 2030
Figure 6-24: Allograft Hip Large Joint Reconstruction Procedures by Country, Europe, 2020 – 2030
Figure 6-25: Allograft Knee Large Joint Reconstruction Procedures by Country, Europe, 2020 – 2030
Figure 6-26: Allograft Foot Reconstruction Procedures by Country, Europe, 2020 – 2030
Figure 6-27: Allograft Craniomaxillofacial Procedures by Country, Europe, 2020 – 2030
Figure 6-28: Allograft Oncology Procedures by Country, Europe, 2020 – 2030
Figure 6-29: DBM Procedures by Country, Europe, 2020 – 2030
Figure 6-30: DBM Procedures by Indication, Europe, 2020 – 2030
Figure 6-31: DBM Cervical Spine Procedures by Country, Europe, 2020 – 2030
Figure 6-32: DBM Thoracolumbar Spine Procedures by Country, Europe, 2020 – 2030
Figure 6-33: DBM Non-Union Trauma Procedures by Country, Europe, 2020 – 2030
Figure 6-34: DBM Fresh Fracture Trauma Procedures by Country, Europe, 2020 – 2030
Figure 6-35: DBM Craniomaxillofacial Procedures by Country, Europe, 2020 – 2030
Figure 6-36: Synthetic Procedures by Country, Europe, 2020 – 2030
Figure 6-37: Synthetic Procedures by Indication, Europe, 2020 – 2030 (1 of 2)
Figure 6-38: Synthetic Procedures by Indication, Europe, 2020 – 2030 (2 of 2)
Figure 6-39: Synthetic Cervical Spine Procedures by Country, Europe, 2020 – 2030
Figure 6-40: Synthetic Thoracolumbar Spine Procedures by Country, Europe, 2020 – 2030
Figure 6-41: Synthetic Non-Union Trauma Procedures by Country, Europe, 2020 – 2030
Figure 6-42: Synthetic Fresh Fracture Trauma Procedures by Country, Europe, 2020 – 2030
Figure 6-43: Synthetic Hip Large Joint Reconstruction Procedures by Country, Europe, 2020 – 2030
Figure 6-44: Synthetic Knee Large Joint Reconstruction Procedures by Country, Europe, 2020 – 2030
Figure 6-45: Synthetic Foot Reconstruction Procedures by Country, Europe, 2020 – 2030
Figure 6-46: Synthetic Craniomaxillofacial Procedures by Country, Europe, 2020 – 2030
Figure 6-47: Synthetic Oncology Procedures by Country, Europe, 2020 – 2030
Figure 6-48: Orthopedic Bone Grafting Procedures by Care Setting, Europe, 2020 – 2030
Figure 6-49: Orthopedic Growth Factor Procedures by Country, Europe, 2020 – 2030
Figure 6-50: Orthopedic Growth Factor Procedures by Indication, Europe, 2020 – 2030
Figure 6-51: Spine Growth Factor Procedures by Country, Europe, 2020 – 2030
Figure 6-52: Tibial Growth Factor Procedures by Country, Europe, 2020 – 2030
Figure 6-53: Orthopedic Growth Factor Procedures by Care Setting, Europe, 2020 – 2030
Figure 6-54: Orthopedic Cell Therapy Procedures by Country, Europe, 2020 – 2030
Figure 6-55: Orthopedic Cell Therapy Procedures by Material Type, Europe, 2020 – 2030
Figure 6-56: Platelet-Rich Plasma Procedures by Country, Europe, 2020 – 2030
Figure 6-57: Bone Marrow Aspirate Concentrate Procedures by Indication, Europe, 2020 – 2030
Figure 6-58: Orthopedic Cell Therapy Procedures by Care Setting, Europe, 2020 – 2030
Figure 6-59: Hyaluronic Acid Viscosupplementation Total Injections by Country, Europe, 2020 – 2030
Figure 6-60: Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle, Europe, 2020 – 2030 (1 of 2)
Figure 6-61: Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle, Europe, 2020 – 2030 (2 of 2)
Figure 6-62: Single-Injection Cycles by Country, Europe, 2020 – 2030
Figure 6-63: Two-Injection Cycles by Country, Europe, 2020 – 2030
Figure 6-64: Three-Injection Cycles by Country, Europe, 2020 – 2030
Figure 6-65: Five-Injection Cycles by Country, Europe, 2020 – 2030
Figure 6-66: Hyaluronic Acid Viscosupplementation Procedures by Care Setting, Europe, 2020 – 2030
Figure 6-67: Orthopedic Cartilage Repair Procedures by Type, Europe, 2020 – 2030
Figure 6-68: Orthopedic Cartilage Repair Procedures by Care Setting, Europe, 2020 – 2030
Figure 7-1: Bone Graft Substitute Market by Segment, Europe, 2020 – 2030 (€M)
Figure 7-2: Bone Graft Substitute Market by Segment, Europe, 2020 – 2030 (US$M)
Figure 7-3: Total Bone Graft Substitute Market, Europe, 2020 – 2030
Figure 7-4: Units Sold by Country, Total Bone Graft Substitute Market, Europe, 2020 – 2030
Figure 7-5: Average Selling Price by Country, Total Bone Graft Substitute Market, Europe, 2020 – 2030 (€)
Figure 7-6: Average Selling Price by Country, Total Bone Graft Substitute Market, Europe, 2020 – 2030 (US$)
Figure 7-7: Market Value by Country, Total Bone Graft Substitute Market, Europe, 2020 – 2030 (€M)
Figure 7-8: Market Value by Country, Total Bone Graft Substitute Market, Europe, 2020 – 2030 (US$M)
Figure 7-9: Allograft Market, Europe, 2020 – 2030
Figure 7-10: Units Sold by Country, Allograft Market, Europe, 2020 – 2030
Figure 7-11: Average Selling Price by Country, Allograft Market, Europe, 2020 – 2030 (€)
Figure 7-12: Average Selling Price by Country, Allograft Market, Europe, 2020 – 2030 (US$)
Figure 7-13: Market Value by Country, Allograft Market, Europe, 2020 – 2030 (€M)
Figure 7-14: Market Value by Country, Allograft Market, Europe, 2020 – 2030 (US$M)
Figure 7-15: Demineralized Bone Matrix Market, Europe, 2020 – 2030
Figure 7-16: Units Sold by Country, Demineralized Bone Matrix Market, Europe, 2020 – 2030
Figure 7-17: Average Selling Price by Country, Demineralized Bone Matrix Market, Europe, 2020 – 2030 (€)
Figure 7-18: Average Selling Price by Country, Total Demineralized Bone Matrix Market, Europe, 2020 – 2030 (US$)
Figure 7-19: Market Value by Country, Total Demineralized Bone Matrix Market, Europe, 2020 – 2030 (€M)
Figure 7-20: Market Value by Country, Total Demineralized Bone Matrix Market, Europe, 2020 – 2030 (US$M)
Figure 7-21: Synthetic Market, Europe, 2020 – 2030
Figure 7-22: Units Sold by Country, Synthetic Market, Europe, 2020 – 2030
Figure 7-23: Average Selling Price by Country, Total Synthetic Market, Europe, 2020 – 2030 (€)
Figure 7-24: Average Selling Price by Country, Total Synthetic Market, Europe, 2020 – 2030 (US$)
Figure 7-25: Market Value by Country, Total Synthetic Market, Europe, 2020 – 2030 (€M)
Figure 7-26: Market Value by Country, Total Synthetic Market, Europe, 2020 – 2030 (US$M)
Figure 7-27: Total Bone Graft Substitute Units Sold by Indication, Europe, 2020 – 2030 (1 of 2)
Figure 7-28: Total Bone Graft Substitute Units Sold by Indication, Europe, 2020 – 2030 (2 of 2)
Figure 7-29: Allograft Bone Graft Substitute Units Sold by Indication, Europe, 2020 – 2030
Figure 7-30: Spine Allograft Bone Graft Substitute Units Sold by Indication, Europe, 2020 – 2030
Figure 7-31: Units Sold by Country, Cervical Spine Allograft Bone Graft Substitute, Europe, 2020 – 2030
Figure 7-32: Units Sold by Country, Thoracolumbar Spine Allograft Bone Graft Substitute, Europe, 2020 – 2030
Figure 7-33: Trauma Allograft Bone Graft Substitute Units Sold by Indication, Europe, 2020 – 2030
Figure 7-34: Units Sold by Country, Non-Union Trauma Allograft Bone Graft Substitute, Europe, 2020 – 2030
Figure 7-35: Units Sold by Country, Fresh Fracture Trauma Allograft Bone Graft Substitute, Europe, 2020 – 2030
Figure 7-36: Large Joint Reconstruction Allograft Bone Graft Substitute Units Sold by Anatomy, Europe, 2020 – 2030
Figure 7-37: Units Sold by Country, Hip Large Joint Reconstruction Allograft Bone Graft Substitute, Europe, 2020 – 2030
Figure 7-38: Units Sold by Country, Knee Large Joint Reconstruction Allograft Bone Graft Substitute, Europe, 2020 – 2030
Figure 7-39: Units Sold by Country, Foot Reconstruction Allograft Bone Graft Substitute, Europe, 2020 – 2030
Figure 7-40: Units Sold by Country, Craniomaxillofacial Allograft Bone Graft Substitute, Europe, 2020 – 2030
Figure 7-41: Units Sold by Country, Oncology Allograft Bone Graft Substitute, Europe, 2020 – 2030
Figure 7-42: Demineralized Bone Matrix Allograft Units Sold by Indication, Europe, 2020 – 2030
Figure 7-43: Spine Demineralized Bone Matrix Allograft Units Sold by Anatomy, Europe, 2020 – 2030
Figure 7-44: Units Sold by Country, Cervical Spine Demineralized Bone Matrix Allograft, Europe, 2020 – 2030
Figure 7-45: Units Sold by Country, Thoracolumbar Spine Demineralized Bone Matrix Allograft, Europe, 2020 – 2030
Figure 7-46: Trauma Demineralized Bone Matrix Allograft Units Sold by Anatomy, Europe, 2020 – 2030
Figure 7-47: Units Sold by Country, Non-Union Trauma Demineralized Bone Matrix Allograft, Europe, 2020 – 2030
Figure 7-48: Units Sold by Country, Fresh Fracture Trauma Demineralized Bone Matrix Allograft, Europe, 2020 – 2030
Figure 7-49: Units Sold by Country, Craniomaxillofacial Demineralized Bone Matrix Allograft, Europe, 2020 – 2030
Figure 7-50: Synthetic Bone Graft Substitute Units Sold by Indication, Europe, 2020 – 2030
Figure 7-51: Spine Synthetic Bone Graft Substitute Units Sold by Anatomy, Europe, 2020 – 2030
Figure 7-52: Units Sold by Country, Cervical Spine Synthetic Bone Graft Substitute, Europe, 2020 – 2030
Figure 7-53: Units Sold by Country, Thoracolumbar Spine Synthetic Bone Graft Substitute, Europe, 2020 – 2030
Figure 7-54: Trauma Synthetic Bone Graft Substitute Units Sold by Indication, Europe, 2020 – 2030
Figure 7-55: Units Sold by Country, Non-Union Trauma Synthetic Bone Graft Substitute, Europe, 2020 – 2030
Figure 7-56: Units Sold by Country, Fresh Fracture Trauma Synthetic Bone Graft Substitute, Europe, 2020 – 2030
Figure 7-57: Large Joint Reconstruction Synthetic Bone Graft Substitute Units Sold by Anatomy, Europe, 2020 – 2030
Figure 7-58: Units Sold by Country, Hip Large Joint Reconstruction Synthetic Bone Graft Substitute, Europe, 2020 – 2030
Figure 7-59: Units Sold by Country, Knee Large Joint Reconstruction Synthetic Bone Graft Substitute, Europe, 2020 – 2030
Figure 7-60: Units Sold by Country, Foot Reconstruction Synthetic Bone Graft Substitute, Europe, 2020 – 2030
Figure 7-61: Units Sold by Country, Craniomaxillofacial Synthetic Bone Graft Substitute, Europe, 2020 – 2030
Figure 7-62: Units Sold by Country, Oncology Synthetic Bone Graft Substitute, Europe, 2020 – 2030
Figure 7-63: Units Sold by Country, Generation 1 Synthetic Bone Graft Substitute, Europe, 2020 – 2030
Figure 7-64: Units Sold by Country, Generation 2 Synthetic Bone Graft Substitute, Europe, 2020 – 2030
Figure 7-65: Leading Competitors by Country, Orthopedic Bone Graft Substitute Market, Europe, 2023
Figure 7-66: Leading Competitors by Segment, Orthopedic Bone Graft Substitute Market, Europe, 2023

$8,995
$9,995
$10,995

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings